| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Franklyn A Howe | Q56090378 |
| P2093 | author name string | C A Clark | |
| J S Axford | |||
| P L Peterson | |||
| P2860 | cites work | Antiribosomal P protein antibodies in systemic lupus erythematosus. A reappraisal | Q40725670 |
| Magnetic resonance imaging of the brain in neuropsychiatric systemic lupus erythematosus | Q46909297 | ||
| Identification of brain lesions in neuropsychiatric systemic lupus erythematosus by magnetic resonance scanning | Q48115666 | ||
| Automated T2 quantitation in neuropsychiatric lupus erythematosus: a marker of active disease. | Q48276597 | ||
| Systemic lupus erythematosus: neuropsychiatric signs and symptoms related to cerebral MRI findings | Q48322650 | ||
| Neurometabolite markers of cerebral injury in the antiphospholipid antibody syndrome of systemic lupus erythematosus. | Q48357005 | ||
| Brain injury and neurometabolic abnormalities in systemic lupus erythematosus. | Q48377371 | ||
| Gadolinium-enhanced magnetic resonance imaging of the central nervous system in systemic lupus erythematosus | Q48423132 | ||
| Association of global brain damage and clinical functioning in neuropsychiatric systemic lupus erythematosus | Q48465933 | ||
| Systemic lupus erythematosus: diagnostic application of magnetization transfer ratio histograms in patients with neuropsychiatric symptoms--initial results | Q48675768 | ||
| Magnetic resonance imaging of the brain and cerebral proton spectroscopy in patients with systemic lupus erythematosus | Q48820031 | ||
| The role of neuroimaging in geriatric psychiatry | Q54075508 | ||
| Proton magnetic resonance spectroscopy of systemic lupus erythematosus involving the central nervous system | Q57089661 | ||
| Sensitivity of quantitative (1)H magnetic resonance spectroscopy of the brain in detecting early neuronal damage in systemic lupus erythematosus | Q28345781 | ||
| Imaging modalities in central nervous system systemic lupus erythematosus | Q30662548 | ||
| Magnetic resonance spectroscopy in multiple sclerosis: window into the diseased brain | Q30696050 | ||
| Temporal lobectomy for epilepsy: recovery of the contralateral hippocampus measured by (1)H MRS. | Q30716820 | ||
| Fast magnetic resonance diffusion-weighted imaging of acute human stroke | Q30929706 | ||
| Evaluation of patients with CNS involvement in SLE. | Q31933342 | ||
| Magnetic resonance and computed tomographic imaging in the evaluation of acute neuropsychiatric disease in systemic lupus erythematosus | Q33562233 | ||
| Controversies in lupus: nervous system involvement | Q33567067 | ||
| Neuroimaging in neuropsychiatric systemic lupus erythematosus | Q33753228 | ||
| Can neurologic manifestations of Hughes (antiphospholipid) syndrome be distinguished from multiple sclerosis? Analysis of 27 patients and review of the literature | Q33835528 | ||
| Human cerebral osmolytes during chronic hyponatremia. A proton magnetic resonance spectroscopy study | Q34202473 | ||
| The central nervous system in systemic lupus erythematosus. Part 2. Pathogenetic mechanisms of clinical syndromes: a literature investigation | Q34669837 | ||
| Brain involvement in systemic immune mediated diseases: magnetic resonance and magnetisation transfer imaging study | Q35455167 | ||
| Continuing ischemic damage after acute middle cerebral artery infarction in humans demonstrated by short-echo proton spectroscopy. | Q36704808 | ||
| Proton magnetic resonance spectroscopy studies on human brain myo-inositol in hypo-osmolarity and hepatic encephalopathy | Q36723487 | ||
| P433 | issue | 12 | |
| P921 | main subject | neuropsychiatric systemic lupus erythematosus | Q9358981 |
| P304 | page(s) | 897-902 | |
| P577 | publication date | 2003-01-01 | |
| P1433 | published in | Lupus | Q6704846 |
| P1476 | title | Quantitative magnetic resonance imaging in neuropsychiatric systemic lupus erythematosus | |
| P478 | volume | 12 |
| Q34896821 | Association between microscopic brain damage as indicated by magnetization transfer imaging and anticardiolipin antibodies in neuropsychiatric lupus |
| Q47566238 | Avoiding diagnostic pitfalls in neuropsychiatric lupus: the importance of attribution |
| Q38186995 | Diagnosis and management of neuropsychiatric SLE. |
| Q42793835 | Diffuse leukoencephalopathy and subacute parkinsonism as an early manifestation of systemic lupus erythematosus |
| Q58695812 | H-magnetic resonance spectroscopy: diagnostic tool in recurrent headache in systemic lupus erythematosus. A case report |
| Q48892142 | In vivo evaluation of brain damage in the course of systemic lupus erythematosus using magnetic resonance spectroscopy, perfusion-weighted and diffusion-tensor imaging |
| Q48607382 | Increased myo-inositol in parietal white and gray matter as a biomarker of poor prognosis in neuropsychiatric lupus: a case report |
| Q40149699 | Neurometabolic changes in normal white matter may predict appearance of hyperintense lesions in systemic lupus erythematosus |
| Q33339985 | Neuropsychological impairment in systemic lupus erythematosus: a comparison with multiple sclerosis |
| Q35555754 | Proton magnetic resonance spectroscopy may predict future brain lesions in SLE patients: a functional multi-imaging approach and follow up. |
| Q55933861 | Systemic lupus erythematosus |
| Q53421838 | Tumor-like cerebral perivasculitis in a pediatric patient with systemic lupus erythematosus. |
Search more.